BioCentury | Apr 1, 1996
Company News

Chiron, Japan Tobacco deal

CHIR granted a non-exclusive license to its combinatorial chemistry technologies to JT's pharmaceutical division. The collaboration initially covers two years and is extendible for up to four years. JT will make undisclosed annual payments to...
Items per page:
1 - 1 of 1
BioCentury | Apr 1, 1996
Company News

Chiron, Japan Tobacco deal

CHIR granted a non-exclusive license to its combinatorial chemistry technologies to JT's pharmaceutical division. The collaboration initially covers two years and is extendible for up to four years. JT will make undisclosed annual payments to...
Items per page:
1 - 1 of 1